# The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel

> **NCT01893281** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 78 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Topical Testosterone Solution

## Key facts

- **NCT ID:** NCT01893281
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2014-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01893281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01893281, "The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01893281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*